A pilot study on therapeutic drug monitoring of asparaginase in Indian children with high-risk ALL: evidence for suboptimal exposure - Top-Institutions - MDSpire

A pilot study on therapeutic drug monitoring of asparaginase in Indian children with high-risk ALL: evidence for suboptimal exposure

  • By

  • Himanshu Dhanda

  • Shamsuz Zaman

  • Bhavika Rishi

  • Raj Kamal

  • Manpreet Kaur

  • Nitika Anand

  • Baseer Noor

  • Pranay Tanwar

  • Sufian Zaheer

  • Prashant Prabhakar

  • Fouzia Siraj

  • Amitabh Singh

  • Aroonima Misra

  • May 21, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Pediatric Oncology

  • #2

    Great Ormond Street Hospital
    Great Ormond Street Hospital

    London, England

    Key Differentiators

    • Pediatric Oncology

  • #3

    The First Affiliated Hospital of Chongqing Medical University
    The First Affiliated Hospital of Chongqing Medical University

    Chongqing, China

    Key Differentiators

    • Pediatric Oncology

Original Source(s)

A pilot study on therapeutic drug monitoring of asparaginase in Indian children with high-risk ALL: evidence for suboptimal exposure

  • by Himanshu Dhanda, Shamsuz Zaman, Bhavika Rishi, Raj Kamal, Manpreet Kaur, Nitika Anand, Baseer Noor, Pranay Tanwar, Sufian Zaheer, Prashant Prabhakar, Fouzia Siraj, Amitabh Singh, Aroonima Misra

  • May 21, 2026

Related Content

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

High-grade astrocytoma with piloid features: a case report of comprehensive management